Candidiasis News and Research

RSS
Candiadiasis, or Thrush, is a fungal infection caused by a group of yeast. There is a score of Candida species, the commonest of which is Candida albicans. They normally inhabit the surfaces and mucus linings of the human body. This includes mouth, vaginal cavity gastrointestinal tract etc.
Astellas reports topline results from isavuconazole Phase 3 study in candidemia and other invasive Candida infections

Astellas reports topline results from isavuconazole Phase 3 study in candidemia and other invasive Candida infections

Researchers discover role of RORC mutations in patients with candidiasis and mycobacteriosis

Researchers discover role of RORC mutations in patients with candidiasis and mycobacteriosis

WPI-led study provides clues to new ways to treat difficult-to-cure fungal infections

WPI-led study provides clues to new ways to treat difficult-to-cure fungal infections

Research: Some immune cells convert into cells that trigger disease

Research: Some immune cells convert into cells that trigger disease

UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

Case Western dental researcher discovers new way to model how T cells cause inflammation in mice

Case Western dental researcher discovers new way to model how T cells cause inflammation in mice

Overview of chlamydia trachomatis infections

Overview of chlamydia trachomatis infections

Astellas' isavuconazole gets FDA orphan drug designation for treatment of invasive candidiasis

Astellas' isavuconazole gets FDA orphan drug designation for treatment of invasive candidiasis

Fluticasone furoate effective in moderate-to-severe asthma

Fluticasone furoate effective in moderate-to-severe asthma

FDA designated Astellas’ isavuconazole as QIDP for treatment of invasive candidiasis

FDA designated Astellas’ isavuconazole as QIDP for treatment of invasive candidiasis

UCB, Dermira enter into licensing agreement for development, commercialization of Cimzia

UCB, Dermira enter into licensing agreement for development, commercialization of Cimzia

UCB announces results from PRECiSE clinical trial of Cimzia in patients with Crohn's disease

UCB announces results from PRECiSE clinical trial of Cimzia in patients with Crohn's disease

Extremely premature babies should not be given drug to prevent fatal fungal infection

Extremely premature babies should not be given drug to prevent fatal fungal infection

Scientists discover protein structure that helps common fungal pathogen to infect humans

Scientists discover protein structure that helps common fungal pathogen to infect humans

BioAlliance Pharma, Daewoong sign new licensing agreement for commercialization of Sitavig in South Korea

BioAlliance Pharma, Daewoong sign new licensing agreement for commercialization of Sitavig in South Korea

Study shows effect of oral fungal yeast in inhibiting thrush

Study shows effect of oral fungal yeast in inhibiting thrush

Viamet announces positive interim results from VT-1161 Phase 2 study in patients with AVVC

Viamet announces positive interim results from VT-1161 Phase 2 study in patients with AVVC

Landes Bioscience releases special issue on sepsis

Landes Bioscience releases special issue on sepsis

Arizona scientists investigate intriguing effects of spaceflight on microbial pathogens

Arizona scientists investigate intriguing effects of spaceflight on microbial pathogens

IBN and IBM discover new medical application for converted PET bottles

IBN and IBM discover new medical application for converted PET bottles